Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 38
1.
Sci Rep ; 13(1): 19302, 2023 11 07.
Article En | MEDLINE | ID: mdl-37935785

Accurate characterization of respiratory bacterial co-infection is critical for guiding empirical antibiotic treatment for hospitalised patients with coronavirus disease 2019 (COVID-19). We retrospectively assessed the clinical and analytical predictors of respiratory bacterial co-infection and described the empirical use of antibiotics in COVID-19 hospitalised patients. Respiratory bacterial co-infection was documented in 6.9% (80/1157) of the patients. The predominant bacteria isolates were Haemophilus influenzae, followed by Streptococcus pneumoniae and Pseudomonas aeruginosa. Respiratory bacterial co-infection was associated with having had a positive culture for a respiratory pathogen in the last year (OR = 25.89), dyslipidaemia (OR = 2.52), heart failure (OR = 7.68), ferritin levels < 402 ng/mL (OR = 2.28), leukocyte count > 8.7 × 109/L (OR = 2.4), and patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids (OR = 12.94). Empirical antibiotic treatment was administered in 42.33% of patients, although it declined across the distinct study periods (p < 0.001). Patients admitted to intensive care units harbouring co-infection exhibited worse outcomes and more bacterial secondary infections. In conclusion, respiratory bacterial co-infection prevalence was low, although it could lead to unfavourable outcomes. Moreover, the percentage of empirical antibiotic treatment remained high. The study's findings allowed the identification of several predictors for respiratory bacterial co-infection and could help implement adequate antibiotic stewardship measures.


Bacterial Infections , COVID-19 , Coinfection , Respiratory Tract Infections , Humans , Coinfection/drug therapy , Coinfection/epidemiology , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Respiratory Tract Infections/microbiology , Hospitals
2.
Gastroenterol. hepatol. (Ed. impr.) ; 46(4): 288-296, Abr. 2023. tab, graf
Article En | IBECS | ID: ibc-218420

Background: Bacterial infections remain one of the main complications in cirrhosis and worsen patients’ prognosis and quality of life. An increase in multidrug resistant microorganism (MDRM) infections among patients with cirrhosis, together with infection-related mortality rates, have been reported in recent years. Therefore, adaptation of the initial empiric antibiotic approach to different factors, particularly the local epidemiology of MDRM infections, has been recommended. We aim to describe the main features, outcomes and risk factors of MDRM infections in patients with cirrhosis. Methods: Prospective registry of all episodes of in-hospital infections occurring among cirrhotic patients admitted within a 2-year period at a single center. Clinical and microbiological data were collected at the time of infection diagnosis, and the in-hospital mortality rate of the infectious episode was registered. Results: A total of 139 infectious episodes were included. The disease-causing microorganism was identified in 90 episodes (65%), of which 31 (22%) were caused by MDRM. The only two factors independently associated with MDRM infections were rectal colonization by MDRM and a nosocomial or healthcare-associated source. The infection-related mortality rate was 18.7%. MDRM infection and a past history of hepatic encephalopathy were independently associated with in-hospital mortality. Conclusions: Almost one fourth of bacterial infections occurring in admitted cirrhotic patients were due to MDRM. Rectal colonization was the most important risk factor for MDRM infections in decompensated cirrhosis. Screening for MDRM rectal colonization in patients admitted for decompensated cirrhosis should be assessed as a tool to improve local empiric antibiotic strategies.(AU)


Antecedentes: Las infecciones bacterianas representan una de las principales complicaciones del paciente cirrótico, empeoran su pronóstico y calidad de vida. Recientemente se ha descrito un aumento de infecciones por microorganismos multiresistentes (MMR) en pacientes cirróticos, con un incremento de la mortalidad relacionada con la infección. Se recomienda adecuar el tratamiento antibiótico empírico inicial a diferentes factores, en particular a la epidemiología local. El objetivo del estudio es describir las principales características clínicas, evolución y factores de riesgo asociados a infecciones por MMR en cirrosis. Métodos: Se registraron todos los episodios de infecciones bacterianas que presentaron los pacientes hospitalizados durante un período de 2 años en un único centro. Se recogieron datos clínicos y microbiológicos en el momento de la infección y la tasa de mortalidad intrahospitalaria. Resultados: Se incluyó un total de 139 episodios de infección. Se identificó el microorganismo responsable de la infección en 90 episodios (65%), de los cuales en 31 (22%) la causa fue un MMR. Los 2 factores asociados independientemente con las infecciones MMR fueron colonización rectal por MMR y origen nosocomial o asociado al sistema sanitario de la infección. La mortalidad intrahospitalaria relacionada con la infección fue del 18,7%. La infección por MMR y tener antecedentes de encefalopatía hepática se asociaron independientemente con la mortalidad intrahospitalaria. Conclusiones: Casi una cuarta parte de las infecciones que aparecen en los pacientes cirróticos hospitalizados son producidas por MMR. La colonización rectal fue el factor de riesgo más importante para infecciones por MMR. El cribado de colonización rectal por MMR en pacientes con cirrosis descompensada debe valorarse como una herramienta para mejorar las estrategias de terapia antibiótica empírica.(AU)


Humans , Male , Aged , Risk Factors , Incidence , Clinical Evolution , Fibrosis , Drug Resistance, Microbial , Bacterial Infections , Retrospective Studies , Gastroenterology
3.
Gastroenterol Hepatol ; 46(4): 288-296, 2023 Apr.
Article En, Es | MEDLINE | ID: mdl-36115630

BACKGROUND: Bacterial infections remain one of the main complications in cirrhosis and worsen patients' prognosis and quality of life. An increase in multidrug resistant microorganism (MDRM) infections among patients with cirrhosis, together with infection-related mortality rates, have been reported in recent years. Therefore, adaptation of the initial empiric antibiotic approach to different factors, particularly the local epidemiology of MDRM infections, has been recommended. We aim to describe the main features, outcomes and risk factors of MDRM infections in patients with cirrhosis. METHODS: Prospective registry of all episodes of in-hospital infections occurring among cirrhotic patients admitted within a 2-year period at a single center. Clinical and microbiological data were collected at the time of infection diagnosis, and the in-hospital mortality rate of the infectious episode was registered. RESULTS: A total of 139 infectious episodes were included. The disease-causing microorganism was identified in 90 episodes (65%), of which 31 (22%) were caused by MDRM. The only two factors independently associated with MDRM infections were rectal colonization by MDRM and a nosocomial or healthcare-associated source. The infection-related mortality rate was 18.7%. MDRM infection and a past history of hepatic encephalopathy were independently associated with in-hospital mortality. CONCLUSIONS: Almost one fourth of bacterial infections occurring in admitted cirrhotic patients were due to MDRM. Rectal colonization was the most important risk factor for MDRM infections in decompensated cirrhosis. Screening for MDRM rectal colonization in patients admitted for decompensated cirrhosis should be assessed as a tool to improve local empiric antibiotic strategies.


Bacterial Infections , Quality of Life , Humans , Prospective Studies , Incidence , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Bacterial Infections/complications , Risk Factors , Liver Cirrhosis/complications , Liver Cirrhosis/epidemiology , Anti-Bacterial Agents/therapeutic use
4.
Sci Rep ; 12(1): 21818, 2022 12 17.
Article En | MEDLINE | ID: mdl-36528712

Monitoring the emergence of new SARS-CoV-2 variants is important to detect potential risks of increased transmission or disease severity. We investigated the identification of SARS-CoV-2 variants from real-time reverse transcriptase polymerase chain reaction (RT-PCR) routine diagnostics data. Cycle threshold (Ct) values of positive samples were collected from April 2021 to January 2022 in the Northern Metropolitan Area of Barcelona (n = 15,254). Viral lineage identification from whole genome sequencing (WGS) was available for 4618 (30.3%) of these samples. Pairwise differences in the Ct values between gene targets (ΔCt) were analyzed for variants of concern or interest circulating in our area. A specific delay in the Ct of the N-gene compared to the RdRp-gene (ΔCtNR) was observed for Alpha, Delta, Eta and Omicron. Temporal differences in ΔCtNR correlated with the dynamics of viral replacement of Alpha by Delta and of Delta by Omicron according to WGS results. Using ΔCtNR, prediction of new variants of concern at early stages of circulation was achieved with high sensitivity and specificity (91.1% and 97.8% for Delta; 98.5% and 90.8% for Omicron). Thus, tracking population-wide trends in ΔCt values obtained from routine diagnostics testing in combination with WGS could be useful for real-time management and response to local epidemics.


COVID-19 , SARS-CoV-2 , Humans , SARS-CoV-2/genetics , COVID-19/diagnosis , COVID-19/epidemiology , Whole Genome Sequencing , Real-Time Polymerase Chain Reaction
5.
mSphere ; 7(6): e0034622, 2022 12 21.
Article En | MEDLINE | ID: mdl-36448779

Limiting outbreaks in long-term care facilities (LTCFs) is a cornerstone strategy to avoid an excess of COVID-19-related morbidity and mortality and to reduce its burden on the health system. We studied a large outbreak that occurred at an LTCF, combining methods of classical and genomic epidemiology analysis. The outbreak lasted for 31 days among residents, with an attack rate of 98% and 57% among residents and staff, respectively. The case fatality rate among residents was 16% (n = 15). Phylogenetic analysis of 59 SARS-CoV-2 isolates revealed the presence of two closely related viral variants in all cases (B.1.177 lineage), revealing a far more complex outbreak than initially thought and suggesting an initial spread driven by staff members. In turn, our results suggest that resident relocations to mitigate viral spread might have increased the risk of infection for staff members, creating secondary chains of transmission that were responsible for prolonging the outbreak. Our results highlight the importance of considering unnoticed chains of transmission early during an outbreak and making an adequate use and interpretation of diagnostic tests. Outbreak containment measures should be carefully tailored to each LTCF. IMPORTANCE The impact of COVID-19 on long-term care facilities (LTCFs) has been disproportionately large due to the high frailty of the residents. Here, we report epidemiological and genomic findings of a large outbreak that occurred at an LTCF, which ultimately affected almost all residents and nearly half of staff members. We found that the outbreak was initially driven by staff members; however, later resident relocation to limit the outbreak resulted in transmission from residents to staff members, evidencing the complexity and different phases of the outbreak. The phylogenetic analysis of SARS-CoV-2 isolates indicated that two closely related variants were responsible for the large outbreak. Our study highlights the importance of combining methods of classical and genomic epidemiology to take appropriate outbreak containment measures in LTCFs.


COVID-19 , SARS-CoV-2 , Humans , SARS-CoV-2/genetics , COVID-19/epidemiology , Spain/epidemiology , Long-Term Care/methods , Phylogeny , Disease Outbreaks , Genomics
6.
Front Microbiol ; 13: 897161, 2022.
Article En | MEDLINE | ID: mdl-35756036

Early detection of pathogen cross-transmission events and environmental reservoirs is needed to control derived nosocomial outbreaks. Whole-genome sequencing (WGS) is considered the gold standard for outbreak confirmation, but, in most cases, it is time-consuming and has elevated costs. Consequently, the timely incorporation of WGS results to conventional epidemiology (CE) investigations for rapid outbreak detection is scarce. Fourier transform infrared spectroscopy (FTIR) is a rapid technique that establishes similarity among bacteria based on the comparison of infrared light absorption patterns of bacterial polysaccharides and has been used as a typing tool in recent studies. The aim of the present study was to evaluate the performance of the FTIR as a first-line typing tool for the identification of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae (ESBL-Kp) outbreaks in the hospital setting in comparison with CE investigations using WGS as the gold standard method. Sixty-three isolates of ESBL-Kp collected from 2018 to 2021 and classified according to CE were typed by both FTIR and WGS. Concordance was measured using the Adjusted Rand index (AR) and the Adjusted Wallace coefficient (AW) for both CE and FTIR clustering considering WGS as the reference method. Both AR and AW were significantly higher for FTIR clustering than CE clustering (0.475 vs. 0.134, p = 0.01, and 0.521 vs. 0.134, p = 0.009, respectively). Accordingly, FTIR inferred more true clustering relationships than CE (38/42 vs. 24/42, p = 0.001). However, a similar proportion of genomic singletons was detected by both FTIR and CE (13/21 vs. 12/21, p = 1). This study demonstrates the utility of the FTIR method as a quick, low-cost, first-line tool for the detection of ESBL-Kp outbreaks, while WGS analyses are being performed for outbreak confirmation and isolate characterization. Thus, clinical microbiology laboratories would benefit from integrating the FTIR method into CE investigations for infection control measures in the hospital setting.

8.
Am J Infect Control ; 48(5): 550-554, 2020 05.
Article En | MEDLINE | ID: mdl-31706545

BACKGROUND: This study examines the incidence, characteristics, and risk factors of surgical site infections (SSIs) after spine surgery and evaluates the efficacy of a preventive intervention. METHODS: This was a quasi-experimental pretest/posttest study in patients undergoing spinal surgery in an orthopedic surgery department from December 2014 to November 2016. Based on the results of the study, we revised the preventive protocol with modification of wound dressing, staff training, and feedback. SSI rates were compared between the pre-intervention (December 2014 to November 2015) and post-intervention (December 2015 to November 2016) periods. The risk factors were analyzed using univariate and multivariate analyses. RESULTS: Of the 139 patients included, 14 cases of SSI were diagnosed, with a significant decrease in the incidence of SSIs from the pre-intervention period to the post-intervention period (19.4% vs 2.6%; P = .001). The etiology was known in 13 cases, with enteric flora being predominant in the pre-intervention group. Univariate analysis showed that age, body mass index, days until sitting and ambulation, and incontinence were statistically significant risk factors. After multivariate analysis, only body mass index and days until ambulation remained significant. When the effect of intervention was adjusted with other risk factors, this variable remained statistically significant. CONCLUSIONS: An intervention that includes modification of wound dressing and early mobilization, as well as staff awareness training, monitoring, and feedback, allowed a significant reduction in the incidence of SSI following spinal surgery, particularly infections caused by enteric flora.


Bandages/statistics & numerical data , Early Ambulation/statistics & numerical data , Lumbar Vertebrae/surgery , Perioperative Care/methods , Surgical Wound Infection/epidemiology , Adult , Aged , Bandages/microbiology , Body Mass Index , Female , Gastrointestinal Microbiome , Humans , Incidence , Infection Control/methods , Male , Middle Aged , Multivariate Analysis , Surgical Wound Infection/microbiology , Surgical Wound Infection/prevention & control , Treatment Outcome
9.
J Infect ; 74(2): 187-194, 2017 02.
Article En | MEDLINE | ID: mdl-27889413

OBJECTIVES: Onco-haematological patients are prone to develop infections, and antibiotic prophylaxis may lead to negative blood cultures. Thus, the microbiological diagnosis and subsequent administration of a targeted antimicrobial therapy is often difficult. The goal of this study was to evaluate the usefulness of IRIDICA (PCR/ESI-MS technology) for the molecular diagnosis of bloodstream infections in this patient group. METHODS: A total of 463 whole blood specimens from different sepsis episodes in 429 patients were analysed using the PCR/ESI-MS platform, comparing the results with those of blood culture and other clinically relevant information. RESULTS: The sensitivity of PCR/ESI-MS by specimen (excluding polymicrobial infections, n = 25) in comparison with blood culture was 64.3% overall, 69.0% in oncological patients, and 59.3% in haematological patients. When comparing with a clinical infection criterion, overall sensitivity rose to 74.7%, being higher in oncological patients (80.0%) than in haematological patients (67.7%). Thirty-one microorganisms isolated by culture were not detected by IRIDICA, whereas 42 clinically relevant pathogens not isolated by culture were detected moleculary. CONCLUSIONS: PCR/ESI-MS offers a reliable identification of pathogens directly from whole blood. While additional studies are needed to confirm our findings, the system showed a lower sensitivity in onco-haematological patients in comparison with previously reported results in patients from the Intensive Care Unit.


Hematologic Neoplasms/complications , Molecular Diagnostic Techniques , Polymerase Chain Reaction , Sepsis/diagnosis , Spectrometry, Mass, Electrospray Ionization , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/complications , Bacteremia/diagnosis , Bacteremia/microbiology , Female , Humans , Intensive Care Units , Male , Middle Aged , Molecular Diagnostic Techniques/instrumentation , Molecular Diagnostic Techniques/methods , Prospective Studies , Sensitivity and Specificity , Sepsis/complications , Sepsis/microbiology , Spectrometry, Mass, Electrospray Ionization/instrumentation , Spectrometry, Mass, Electrospray Ionization/methods , Young Adult
12.
Reumatol. clín. (Barc.) ; 11(6): 381-386, nov.-dic. 2015. tab, ilus, graf
Article Es | IBECS | ID: ibc-146764

Introducción. La artritis séptica por Staphylococcus aureus resistente a la meticilina (SARM) es una infección grave que ha aumentado su incidencia en los últimos 10años. Métodos. Estudio retrospectivo (1984-2011) en el que se realiza una descripción de las características clínicas y epidemiológicas de las artritis por SARM en adultos y se comparan después las infecciones en articulación nativa causadas por SARM vs Staphylococcus aureus sensible a la meticilina (SASM). Resultados. Se incluyeron 14 infecciones por SARM (7 sobre articulación nativa, 5 protésicas y 2 bursas). Ningún caso fue poliarticular. Tenían importante comorbilidad, aunque ninguno con artritis reumatoide. Siete pacientes presentaron bacteriemia. Cuatro requirieron tratamiento quirúrgico. Seis fallecieron. Se compararon los 7 pacientes con infección de articulación nativa por SARM con los 17 casos causados por SASM. No se encontraron diferencias significativas en los factores de riesgo, excepto más neoplasias en el grupo SARM. La infección fue poliarticular en 7 casos (41%) del grupo SASM. La bacteriemia fue más frecuente en el grupo SARM (71,4 vs 58,8%). El antibiótico empírico resultó apropiado en el 28,6% de los casos SARM, frente al 100% de los casos SASM. Existió mayor tendencia a la mortalidad en las artritis por SARM (57,1% vs 17,6%, p=0,07). Conclusión. La artritis séptica por SARM es una entidad grave que acontece en pacientes ancianos y con gran comorbilidad. Es generalmente monoarticular, con hemocultivos positivos y mayor mortalidad que la artritis por SASM. En los pacientes de riesgo el tratamiento antibiótico empírico indicado es la vancomicina (AU)


Introduction. Septic arthritis due to methylcyllin resistant Staphylococcus aureus (MRSA) is a serious infection that has increased in incidence in the past 10years. Methods. We conducted a retrospective study (1984-2011) in which a description of the clinical and epidemiological characteristics of MRSA arthritis in adults was performed and then compared to native joint infections caused by MRSA vs. methylcyllin sensitive Staphylococcus aureus (MSSA). Results. Fourteen MRSA infections were included (7 native joint, 5 prosthetic and 2 bursae). No case was polyarticular. There was significant comorbidity, although none was associated to rheumatoid arthritis. Seven patients had bacteremia. Four required surgical treatment. Six died. When comparing the 7 patients with native joint MRSA infection with the 17 cases caused by MSSA, no significant differences in risk factors were seen, except more malignancies in the MRSA group. The infection was polyarticular in 7 cases (41%) of the MSSA group. Bacteremia was more frequent in the MRSA group (71.4 vs 58.8%). Empirical antibiotic was useful in 28.6% of MRSA cases versus 100% of MSSA cases. There was a greater tendency to associated mortality in MRSA arthritis (57.1% vs 17.6%, P=.07). Conclusions. MRSA septic arthritis is a serious condition that occurs in the elderly and patients with high comorbidity. It is usually monoarticular, with positive blood cultures and higher mortality than MSSA arthritis. In patients at risk, vancomycin empiric antibiotic therapy is indicated (AU)


Humans , Arthritis, Infectious/epidemiology , Staphylococcal Infections/epidemiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Retrospective Studies , Prosthesis-Related Infections/epidemiology , Risk Factors
13.
PLoS One ; 10(10): e0140865, 2015.
Article En | MEDLINE | ID: mdl-26474394

BACKGROUND: Rapid identification of the etiological agent in bloodstream infections is of vital importance for the early administration of the most appropriate antibiotic therapy. Molecular methods may offer an advantage to current culture-based microbiological diagnosis. The goal of this study was to evaluate the performance of IRIDICA, a platform based on universal genetic amplification followed by mass spectrometry (PCR/ESI-MS) for the molecular diagnosis of sepsis-related pathogens directly from the patient's blood. METHODS: A total of 410 whole blood specimens from patients admitted to Emergency Room (ER) and Intensive Care Unit (ICU) with clinical suspicion of sepsis were tested with the IRIDICA BAC BSI Assay (broad identification of bacteria and Candida spp.). Microorganisms grown in culture and detected by IRIDICA were compared considering blood culture as gold standard. When discrepancies were found, clinical records and results from other cultures were taken into consideration (clinical infection criterion). RESULTS: The overall positive and negative agreement of IRIDICA with blood culture in the analysis by specimen was 74.8% and 78.6%, respectively, rising to 76.9% and 87.2% respectively, when compared with the clinical infection criterion. Interestingly, IRIDICA detected 41 clinically significant microorganisms missed by culture, most of them from patients under antimicrobial treatment. Of special interest were the detections of one Mycoplasma hominis and two Mycobacterium simiae in immunocompromised patients. When ICU patients were analyzed separately, sensitivity, specificity, positive and negative predictive values compared with blood culture were 83.3%, 78.6%, 33.9% and 97.3% respectively, and 90.5%, 87.2%, 64.4% and 97.3% respectively, in comparison with the clinical infection criterion. CONCLUSIONS: IRIDICA is a promising technology that offers an early and reliable identification of a wide variety of pathogens directly from the patient's blood within 6h, which brings the opportunity to improve management of septic patients, especially for those critically ill admitted to the ICU.


Blood/microbiology , Molecular Diagnostic Techniques/methods , Polymerase Chain Reaction/methods , Sepsis/blood , Sepsis/diagnosis , Spectrometry, Mass, Electrospray Ionization/methods , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial/genetics , Emergency Service, Hospital , Female , Humans , Intensive Care Units , Male , Middle Aged , Sepsis/microbiology , Young Adult
14.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 33(7): 446-450, ago.-sept. 2015. tab, graf
Article Es | IBECS | ID: ibc-140507

OBJETIVOS: Estudiar la evolución de la incidencia de sepsis neonatal precoz (SNP) por Streptococcus agalactiae en el área de Barcelona y analizar los fallos de cumplimiento del protocolo de prevención. MÉTODOS: Se revisaron retrospectivamente todas las SNP en 8 centros sanitarios del área de Barcelona durante 2004-2010. RESULTADOS: Se diagnosticaron 49 SNP (48 gestantes). La incidencia fue de 0,29‰ recién nacidos vivos (0,18-0,47‰), presentando oscilaciones sin diferencias significativas a lo largo de los 7 años de estudio. La mortalidad fue del 8,16%. En el 68,5% los estudios de colonización maternos fueron negativos y en el 21% no se realizaron. El 58,3% de las gestantes no presentaron ningún factor de riesgo y el 22,9% de los partos fueron prematuros. El 58% de las gestantes no recibieron profilaxis antibiótica intraparto por no estar indicada según protocolo, y el 42%, por fallo de cumplimiento (3 cepas fueron resistentes a eritromicina). La resistencia a clindamicina fue del 33,3%. Los serotipos de Streptococcus agalactiae más frecuentes fueron el III, el V y el ia. CONCLUSIONES: No se han producido cambios significativos en la incidencia de SNP por Streptococcus agalactiae en los 7 años del estudio. El aumento de la sensibilidad de los métodos de cribado, las técnicas moleculares intraparto, la realización del antibiograma de las cepas de gestantes y la mayor comunicación entre los centros sanitarios pueden contribuir a una mejor aplicación del protocolo y a una reducción de la incidencia de SNP


OBJECTIVES: To study the evolution of the incidence of early-onset neonatal sepsis (EOS) by Streptococcus agalactiae in the area of Barcelona and to analyze failure of compliance with the prevention protocol. METHODS: A retrospective review was carried out on EOS cases in 8 Health-Care Centers in the Barcelona area between 2004 and 2010. RESULTS: Forty-nine newborns from 48 mothers were diagnosed with EOS. The incidence was 0.29‰ living newborns (0.18-0.47‰), with no significant differences in the fluctuations along the 7 years. The mortality rate was 8.16%. In 68.5% cases the maternal colonization studies were negative, and in 21% these studies were not performed. No risk factors were detected in 58.3% of pregnant women, and 22.9% of births were premature. In 58% of cases intra-partum antibiotic prophylaxis was not administered because it was not indicated, and in 42% due to failure to follow the protocol (3 strains were resistant to erythromycin). Resistance to clindamycin was 33.3%. The Streptococcus agalactiae serotypes more frequently isolated were III, V, and ia. CONCLUSIONS: No significant changes were detected in the incidence of Streptococcus agalactiae EOS in the 7 years of the study. The increased sensitivity of screening methods with the use of molecular techniques, the performance of susceptibility testing of strains isolated from pregnant women, and the improvement of communication between Health-Care Centers, can contribute to a better implementation of the protocol, as well as to reduce the incidence of EOS


Female , Humans , Infant, Newborn , Male , Sepsis/epidemiology , Sepsis/microbiology , Early Diagnosis , Streptococcus agalactiae/isolation & purification , Clindamycin , Pre-Exposure Prophylaxis/methods , Clinical Protocols , Retrospective Studies , Antibiotic Prophylaxis , Indicators of Morbidity and Mortality
15.
Reumatol Clin ; 11(6): 381-6, 2015.
Article En, Es | MEDLINE | ID: mdl-25746826

INTRODUCTION: Septic arthritis due to methylcyllin resistant Staphylococcus aureus (MRSA) is a serious infection that has increased in incidence in the past 10years. METHODS: We conducted a retrospective study (1984-2011) in which a description of the clinical and epidemiological characteristics of MRSA arthritis in adults was performed and then compared to native joint infections caused by MRSA vs. methylcyllin sensitive Staphylococcus aureus (MSSA). RESULTS: Fourteen MRSA infections were included (7 native joint, 5 prosthetic and 2 bursae). No case was polyarticular. There was significant comorbidity, although none was associated to rheumatoid arthritis. Seven patients had bacteremia. Four required surgical treatment. Six died. When comparing the 7 patients with native joint MRSA infection with the 17 cases caused by MSSA, no significant differences in risk factors were seen, except more malignancies in the MRSA group. The infection was polyarticular in 7 cases (41%) of the MSSA group. Bacteremia was more frequent in the MRSA group (71.4 vs 58.8%). Empirical antibiotic was useful in 28.6% of MRSA cases versus 100% of MSSA cases. There was a greater tendency to associated mortality in MRSA arthritis (57.1% vs 17.6%, P=.07). CONCLUSIONS: MRSA septic arthritis is a serious condition that occurs in the elderly and patients with high comorbidity. It is usually monoarticular, with positive blood cultures and higher mortality than MSSA arthritis. In patients at risk, vancomycin empiric antibiotic therapy is indicated.


Arthritis, Infectious , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Adult , Aged , Aged, 80 and over , Arthritis, Infectious/diagnosis , Arthritis, Infectious/epidemiology , Arthritis, Infectious/etiology , Arthritis, Infectious/therapy , Comorbidity , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Spain , Staphylococcal Infections/diagnosis , Staphylococcal Infections/epidemiology , Staphylococcal Infections/etiology , Staphylococcal Infections/therapy , Tertiary Care Centers , Treatment Outcome
16.
Enferm Infecc Microbiol Clin ; 33(7): 446-50, 2015.
Article Es | MEDLINE | ID: mdl-25541009

OBJECTIVES: To study the evolution of the incidence of early-onset neonatal sepsis (EOS) by Streptococcus agalactiae in the area of Barcelona and to analyze failure of compliance with the prevention protocol. METHODS: A retrospective review was carried out on EOS cases in 8 Health-Care Centers in the Barcelona area between 2004 and 2010. RESULTS: Forty-nine newborns from 48 mothers were diagnosed with EOS. The incidence was 0.29‰ living newborns (0.18-0.47‰), with no significant differences in the fluctuations along the 7 years. The mortality rate was 8.16%. In 68.5% cases the maternal colonization studies were negative, and in 21% these studies were not performed. No risk factors were detected in 58.3% of pregnant women, and 22.9% of births were premature. In 58% of cases intra-partum antibiotic prophylaxis was not administered because it was not indicated, and in 42% due to failure to follow the protocol (3 strains were resistant to erythromycin). Resistance to clindamycin was 33.3%. The Streptococcus agalactiae serotypes more frequently isolated were iii, v, and ia. CONCLUSIONS: No significant changes were detected in the incidence of Streptococcus agalactiae EOS in the 7 years of the study. The increased sensitivity of screening methods with the use of molecular techniques, the performance of susceptibility testing of strains isolated from pregnant women, and the improvement of communication between Health-Care Centers, can contribute to a better implementation of the protocol, as well as to reduce the incidence of EOS.


Neonatal Sepsis/epidemiology , Streptococcal Infections/epidemiology , Streptococcus agalactiae/isolation & purification , Age of Onset , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis/statistics & numerical data , Cesarean Section/statistics & numerical data , Delayed Diagnosis , Delivery, Obstetric , False Negative Reactions , Female , Humans , Incidence , Infant, Newborn , Neonatal Sepsis/drug therapy , Neonatal Sepsis/microbiology , Neonatal Sepsis/prevention & control , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Retrospective Studies , Risk Factors , Spain/epidemiology , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcal Infections/prevention & control , Urban Population
17.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 32(10): 654-661, dic. 2014. ilus, tab
Article Es | IBECS | ID: ibc-130109

IINTRODUCCIÓN: Los programas de control de uso de antibióticos suelen incluir intervenciones basadas en recomendaciones no impositivas a los prescriptores. Interesa conocer los factores relacionados con la adherencia a las recomendaciones y su funcionamiento en la práctica real. MÉTODOS: Estudio multicéntrico, controlado y aleatorizado, realizado en 32 unidades de hospitalización. Especialistas en enfermedades infecciosas revisaron, alrededor del tercer día, las prescripciones de antibióticos, estableciendo recomendaciones. Describimos la implantación de la intervención, analizamos los factores asociados al seguimiento de las recomendaciones y el impacto de la intervención. RESULTADOS: Se realizaron 3.192 intervenciones. Las fuentes de información empleadas para la elaboración de las recomendaciones variaron significativamente entre los centros. En el 65% se recomendó alguna modificación del tratamiento: suspender los antibióticos (47%), modificar la vía de administración (26%), cambiar o variar el número de antibióticos (27%) y cambiar la dosis (5%). En el 75% se recomendó simplificar el tratamiento. La adherencia fue del 68%, con variaciones significativas entre los centros, y fue mayor cuando se recomendó ajuste de dosis o cambio de vía, durante el primer periodo del estudio y cuando las recomendaciones se realizaban, además de por escrito, verbalmente. No se pudo constatar impacto en el consumo de antibióticos ni en la incidencia de patógenos resistentes. CONCLUSIONES: Una elevada proporción de tratamientos antibióticos son susceptibles de modificación, generalmente hacia la simplificación. La adherencia a las recomendaciones fue elevada, aunque variable, dependiendo del centro, del tipo de recomendación, del periodo del estudio y de que la recomendación se realizara mediante un comentario verbal además de escrito


INTRODUCTION: Stewardship programs on the use of antibiotics usually include interventions based on non-compulsory recommendations for the prescribers. Factors related to the adherence to expert recommendations, and the implementation of these programmes in daily practice, are of interest. METHODS: A randomized, controlled, multicentre intervention study was performed in 32 hospitalization units. Antibiotic prescriptions were evaluated by an infectious disease specialist on the third day. We describe the implementation of the intervention, the factors associated with adherence to recommendations, and the impact of the intervention. RESULTS: A total of 3,192 interventions were carried out. Information sources used to prepare the recommendations varied significantly between centres. A modification was recommended in 65% of cases: withdrawal (47%), change in administration route (26%), change of drugs or number of antibiotics (27%), and change in dose (5%). Simplification of treatment accounted for 75% of all recommendations. Adherence was 68%, with significant differences between hospitals, and higher when the recommendations consisted of a dose adjustment or change of route, during the first intervention period, and also when recommendations were personally commented on, in addition to writing a note in the clinical chart. We did not find any reduction in antibiotic consumption or variation in the incidence of resistant pathogens. CONCLUSIONS: An important proportion of antibiotic prescriptions may be susceptible to improvement, most of them towards simplification. The adherence to the intervention was high, but significant variations at different centres were observed, depending on the type of recommendation, and the study period. Those recommendations that were personally commented on were more followed more than those only written


Humans , Male , Female , Middle Aged , Anti-Infective Agents/metabolism , Anti-Infective Agents/therapeutic use , Medication Adherence/statistics & numerical data , Hospitalization/statistics & numerical data , Hospitalization/trends , Anti-Infective Agents/pharmacology , Anti-Infective Agents/standards , Logistic Models , Social Impact Indicators , Health Impact Assessment/methods
18.
Biomed Res Int ; 2014: 501214, 2014.
Article En | MEDLINE | ID: mdl-24818144

The reference method for the diagnosis of bloodstream infections is blood culture followed by biochemical identification and antibiotic susceptibility testing of the isolated pathogen. This process requires 48 to 72 hours. The rapid administration of the most appropriate antimicrobial treatment is crucial for the survival of septic patients; therefore, a rapid method that enables diagnosis directly from analysis of a blood sample without culture is needed. A recently developed platform that couples broad-range PCR amplification of pathogen DNA with electrospray ionization mass spectrometry (PCR/ESI-MS) has the ability to identify virtually any microorganism from direct clinical specimens. To date, two clinical evaluations of the PCR/ESI-MS technology for the diagnosis of bloodstream infections from whole blood have been published. Here we discuss them and describe recent improvements that result in an enhanced sensitivity. Other commercially available assays for the molecular diagnosis of bloodstream infections from whole blood are also reviewed. The use of highly sensitive molecular diagnostic methods in combination with conventional procedures could substantially improve the management of septic patients.


Bacterial Infections/blood , Bacterial Infections/diagnosis , Mass Spectrometry/methods , Polymerase Chain Reaction/methods , Animals , Humans , Molecular Diagnostic Techniques , Reagent Kits, Diagnostic
19.
Enferm Infecc Microbiol Clin ; 32(10): 654-61, 2014 Dec.
Article Es | MEDLINE | ID: mdl-24813928

INTRODUCTION: Stewardship programs on the use of antibiotics usually include interventions based on non-compulsory recommendations for the prescribers. Factors related to the adherence to expert recommendations, and the implementation of these programmes in daily practice, are of interest. METHODS: A randomized, controlled, multicentre intervention study was performed in 32 hospitalization units. Antibiotic prescriptions were evaluated by an infectious disease specialist on the third day. We describe the implementation of the intervention, the factors associated with adherence to recommendations, and the impact of the intervention. RESULTS: A total of 3,192 interventions were carried out. Information sources used to prepare the recommendations varied significantly between centres. A modification was recommended in 65% of cases: withdrawal (47%), change in administration route (26%), change of drugs or number of antibiotics (27%), and change in dose (5%). Simplification of treatment accounted for 75% of all recommendations. Adherence was 68%, with significant differences between hospitals, and higher when the recommendations consisted of a dose adjustment or change of route, during the first intervention period, and also when recommendations were personally commented on, in addition to writing a note in the clinical chart. We did not find any reduction in antibiotic consumption or variation in the incidence of resistant pathogens. CONCLUSIONS: An important proportion of antibiotic prescriptions may be susceptible to improvement, most of them towards simplification. The adherence to the intervention was high, but significant variations at different centres were observed, depending on the type of recommendation, and the study period. Those recommendations that were personally commented on were more followed more than those only written.


Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Drug Prescriptions/standards , Guideline Adherence/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Child , Humans , Middle Aged , Time Factors , Young Adult
20.
J Clin Microbiol ; 51(11): 3585-90, 2013 Nov.
Article En | MEDLINE | ID: mdl-23966486

In this study, we analyzed the clinical and molecular epidemiology of invasive serotype 5 (Ser5) pneumococcal isolates in four teaching hospitals in the Barcelona, Spain, area (from 1997 to 2011). Among 5,093 invasive pneumococcal isolates collected, 134 (2.6%) Ser5 isolates were detected. Although the overall incidence of Ser5-related invasive pneumococcal disease (IPD) was low (0.25 cases/100,000 inhabitants), three incidence peaks were detected: 0.63/100,000 in 1999, 1.15/100,000 in 2005, and 0.37/100,000 in 2009. The rates of Ser5 IPD were higher among young adults (18 to 64 years old) and older adults (>64 years old) in the first two peaks, whereas they were higher among children in 2009. The majority (88.8%) of the patients presented with pneumonia. Comorbid conditions were present in young adults (47.6%) and older adults (78.7%), the most common comorbid conditions being chronic obstructive pulmonary disease (20.6% and 38.3%, respectively) and cardiovascular diseases (11.1% and 38.3%, respectively). The mortality rates were higher among older adults (8.5%). All Ser5 pneumococci tested were fully susceptible to penicillin, cefotaxime, erythromycin, and ciprofloxacin. The resistance rates were 48.5% for co-trimoxazole, 6.7% for chloramphenicol, and 6% for tetracycline. Two major related sequence types (STs), ST1223 (n = 65) and ST289 (n = 61), were detected. The Colombia(5)-ST289 clone was responsible for all the cases in the Ser5 outbreak in 1999, whereas the ST1223 clone accounted for 73.8% and 61.5% of the isolates in 2005 and 2009, respectively. Ser5 pneumococci are a frequent cause of IPD outbreaks in the community and involve children and adults with or without comorbidities. The implementation of the new pneumococcal conjugated vaccines (PCV10 and PCV13) might prevent such outbreaks.


Disease Outbreaks , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Child , Child, Preschool , Female , Hospitals, Teaching , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Molecular Epidemiology , Pneumococcal Infections/complications , Pneumococcal Infections/mortality , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/etiology , Serotyping , Spain/epidemiology , Streptococcus pneumoniae/drug effects , Survival Analysis , Young Adult
...